Suppr超能文献

2019冠状病毒病糖尿病患者的严重程度和死亡率主要特征及严重程度风险评分的建立

Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.

作者信息

Xiao Yu-Feng, He Jia-Lin, Xu Yu, Liu Xi, Lin Hui, Li Qi, Xu Zhi, Hu Ming-Dong, Ren Xiao-Bao, Zhang Cheng, Zhang Wen-Jing, Duan Wei, Tian Yong-Feng, Li Ping, Wu Hao, Song Cai-Ping, Liu En, Yang Shi-Ming

机构信息

Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China.

Huo-Shen-Shan Hospital, Wuhan, China.

出版信息

Front Med (Lausanne). 2021 Jun 7;8:655604. doi: 10.3389/fmed.2021.655604. eCollection 2021.

Abstract

Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk factors associated in diabetic patients with COVID-19. A prediction model was built based on these risk factors. The risk factors for higher mortality in diabetic patients with COVID-19 were dyspnea, lung disease, cardiovascular diseases, neutrophil, PLT count, and CKMB. Similarly, dyspnea, cardiovascular diseases, neutrophil, PLT count, and CKMB were risk factors related to the severity of diabetes with COVID-19. Based on these factors, a risk score was built to predict the severity of disease in diabetic patients with COVID-19. Patients with a score of 7 or higher had an odds ratio of 7.616. Dyspnea is a critical clinical manifestation that is closely related to the severity of disease in diabetic patients with COVID-19. Attention should also be paid to the neutrophil, PLT count and CKMB levels after admission.

摘要

糖尿病是新型冠状病毒肺炎(COVID-19)预后不良的一个危险因素。分析COVID-19糖尿病患者的相关预后因素将有助于对此类患者进行进一步治疗。这项回顾性研究纳入了3623例COVID-19患者(其中325例患有糖尿病)。收集了糖尿病组和非糖尿病组的临床特征及实验室检查结果并进行比较。采用二元逻辑回归分析来探究COVID-19糖尿病患者的相关危险因素。基于这些危险因素建立了一个预测模型。COVID-19糖尿病患者死亡率较高的危险因素包括呼吸困难、肺部疾病、心血管疾病、中性粒细胞、血小板计数和肌酸激酶同工酶(CKMB)。同样,呼吸困难、心血管疾病、中性粒细胞、血小板计数和CKMB是与COVID-19糖尿病严重程度相关的危险因素。基于这些因素,构建了一个风险评分来预测COVID-19糖尿病患者的疾病严重程度。评分7分及以上的患者优势比为7.616。呼吸困难是一种关键的临床表现,与COVID-19糖尿病患者的疾病严重程度密切相关。入院后还应关注中性粒细胞、血小板计数和CKMB水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1174/8215148/4b9a0d2b16f4/fmed-08-655604-g0001.jpg

相似文献

1
Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score.
Front Med (Lausanne). 2021 Jun 7;8:655604. doi: 10.3389/fmed.2021.655604. eCollection 2021.
3
[Correlation between early inflammation indicators and the severity of coronavirus disease 2019].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Feb;33(2):145-149. doi: 10.3760/cma.j.cn121430-20200515-00387.
5
CANPT Score: A Tool to Predict Severe COVID-19 on Admission.
Front Med (Lausanne). 2021 Feb 18;8:608107. doi: 10.3389/fmed.2021.608107. eCollection 2021.
6
Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes.
Infect Dis Ther. 2020 Dec;9(4):981-1002. doi: 10.1007/s40121-020-00359-6. Epub 2020 Oct 28.
7
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
Platelets. 2020 Jul 3;31(5):674-679. doi: 10.1080/09537104.2020.1760230. Epub 2020 May 5.
9
Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Pan Afr Med J. 2020 Sep 8;37:32. doi: 10.11604/pamj.2020.37.32.25192. eCollection 2020.
10
The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan.
PLoS One. 2020 Dec 31;15(12):e0243602. doi: 10.1371/journal.pone.0243602. eCollection 2020.

引用本文的文献

本文引用的文献

1
Gut, metabolism and nutritional Support for COVID-19: Experiences from China.
Burns Trauma. 2020 Dec 21;8:tkaa048. doi: 10.1093/burnst/tkaa048. eCollection 2020.
2
Cardiac manifestations in COVID-19 patients-A systematic review.
J Card Surg. 2020 Aug;35(8):1988-2008. doi: 10.1111/jocs.14808. Epub 2020 Jul 11.
5
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
6
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001343.
7
Managing chronic wounds during novel coronavirus pneumonia outbreak.
Burns Trauma. 2020 Apr 7;8:tkaa016. doi: 10.1093/burnst/tkaa016. eCollection 2020.
8
COVID-19 pandemic, coronaviruses, and diabetes mellitus.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
9
COVID-19 and Italy: what next?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验